periodontal disease in type 1 Diabetes Mellitus Patients
- Conditions
- Health Condition 1: null- patients with type 1 Diabetes Melllitus
- Registration Number
- CTRI/2018/04/013275
- Lead Sponsor
- Dr INDU V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 128
INCLUSION CRITERIA
A. For T1DM Group
1. Patients diagnosed with T1DM at least 1 year before the time of periodontal
status assessment
2. Patients above the age of 12.
3. Minimum of 20 teeth present
B. For Control Group
1. Individuals above the age of 12.
2. Non diabetic systemically healthy individuals who are willing to sign informed
consent
3. Minimum of 20 teeth present
EXCLUSION CRITERIA
A. For T1DM Group
1. Patients with other systemic diseases which may affect the periodontal status
(Osteoporosis , Rheumatoid Arthritis etc),
2. pregnant and lactating mothers
3. Patients taking medications which may affect the periodontal status (Nifedipine,
Cyclosporine, Phenytoin etc)
4. Patients with acute condition that contraindicate a periodontal examination.
5. Patients who received periodontal therapy past 1 year.
6. Patients not willing to sign informed consent
B. For Control Group
1. Individuals who received systemic antibiotic therapy within past 6 month and
periodontal therapy past 1 year.
2. Pregnancy
3. Lactating mothers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the proportion and severity of periodontal disease in T1DM patients as <br/ ><br>compared to control group.Timepoint: the primary outcome variable is assessed at a single point of time ( over the study period of 6 months)
- Secondary Outcome Measures
Name Time Method whether any relation exist between the duration of T1DM, dosage of <br/ ><br>Insulin and periodontal disease severity.Timepoint: the secondary outcome variables are assessed at a single point of time ( over the study period of 6 months)